Comments
Loading...

LakeShore Biopharma

LSBNASDAQ
Logo brought to you by Benzinga Data
$2.81
0.197.25%
At close: -
$2.89
0.082.85%
After Hours: Jan 27, 8:59 AM EDT

LakeShore Biopharma (NASDAQ:LSB) Stock, Earnings Estimates, EPS, And Revenue

LakeShore Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Dec 19
EPS
$0.020
Quarterly Revenue
$53.08M
Annual Revenue
(as of Sep 30)
$672.27M

Analyze the earnings history of LakeShore Biopharma using advanced sorting and filters.

Data brought to you by Benzinga APIs

LakeShore Biopharma (LSB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q42024-08-15$-1.90$-0.90-111.1 %
Q32024-04-19$-1.20$-0.70-71.4 %
Q22024-01-22$-1.60$-0.80-100.0 %

LakeShore Biopharma (LSB) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q42024-08-15$3.77M$24.25M-84.5 %
Q32024-04-19$23.82M$22.84M4.27 %
Q22024-01-22$13.64M$23.11M-41.0 %

FAQ

Q

When is LakeShore Biopharma (NASDAQ:LSB) reporting earnings?

A

LakeShore Biopharma (LSB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on December 19, 2024 for H1.

Q

What were the latest earnings per share (EPS) for LakeShore Biopharma (NASDAQ:LSB)?

A

LakeShore Biopharma (LSB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on December 19, 2024 for H1 and the Actual EPS was $0.02, which beat the estimate of $0.00.

Q

What were LakeShore Biopharma’s (NASDAQ:LSB) revenues?

A

LakeShore Biopharma (LSB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on December 19, 2024 for H1 and the Actual Revenue was $53.1M, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.